Anthem Biosciences Ltd.
•₹ 871.45-0.35%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Contract Manufacturing Development & Discovery Services (CRDMO ): 83.4% • Speciality Ingredients: 16.6%
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 27.5%
- Company has a good return on equity (ROE) track record: 3 Years ROE 21.0%
- Company has consistently been profitable over the last 5 years
- Company comfortably covers its interest (117.8x coverage)
- Institutional investors have been accumulating - FII+DII up 11.0pp
CONS
- Promoter holding has decreased over last 2 years: -12.6pp
- Receivables are growing faster than sales - a possible quality concern
- Stock is trading at 12.3x its book value
- Operating margins have contracted to 38.2% from 48.1%
- Expensive relative to growth - PEG of 5.6
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | ANTHEM | 881.75 | 86.26 | 49678.50 | 0.23 | 1199.41 | 783.28 | 4182.18 | 674.18 | 29.62 | 36.00 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 339 | 525 | 498 | 483 | 540 | 550 | 423 | 611 | 418 | |
| 218 | 330 | 338 | 288 | 349 | 332 | 266 | 344 | 299 | |
| Operating Profit | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — |
| Other Income | 19 | 28 | 24 | 14 | 23 | 48 | 34 | 51 | 25 |
| Interest | 4 | 4 | 3 | 1 | 2 | 3 | 0 | 2 | 1 |
| Depreciation | 19 | 20 | 20 | 30 | 26 | 34 | 35 | 40 | 30 |
| 118 | 200 | 161 | 178 | 186 | 230 | 130 | 278 | 145 | |
| Tax % | 30.17% | 18.85% | 22.80% | 53.66% | 27.09% | 24.46% | 28.86% | 31.72% | 17.04% |
| Net Profit | 0 | 0 | 0 | 0 | 136 | 173 | 93 | 190 | 120 |
| 1 | 3 | 2 | 1 | 2 | 3 | 2 | 3 | 0 | |
| Equity Capital | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 113 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 113 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2024
- 339
- 218
- Operating Profit
- —
- OPM %
- —
- Other Income
- 19
- Interest
- 4
- Depreciation
- 19
- 118
- Tax %
- 30.17%
- Net Profit
- 0
- 1
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 525
- 330
- Operating Profit
- —
- OPM %
- —
- Other Income
- 28
- Interest
- 4
- Depreciation
- 20
- 200
- Tax %
- 18.85%
- Net Profit
- 0
- 3
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 498
- 338
- Operating Profit
- —
- OPM %
- —
- Other Income
- 24
- Interest
- 3
- Depreciation
- 20
- 161
- Tax %
- 22.80%
- Net Profit
- 0
- 2
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 483
- 288
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 1
- Depreciation
- 30
- 178
- Tax %
- 53.66%
- Net Profit
- 0
- 1
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 540
- 349
- Operating Profit
- —
- OPM %
- —
- Other Income
- 23
- Interest
- 2
- Depreciation
- 26
- 186
- Tax %
- 27.09%
- Net Profit
- 136
- 2
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 550
- 332
- Operating Profit
- —
- OPM %
- —
- Other Income
- 48
- Interest
- 3
- Depreciation
- 34
- 230
- Tax %
- 24.46%
- Net Profit
- 173
- 3
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 423
- 266
- Operating Profit
- —
- OPM %
- —
- Other Income
- 34
- Interest
- 0
- Depreciation
- 35
- 130
- Tax %
- 28.86%
- Net Profit
- 93
- 2
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 611
- 344
- Operating Profit
- —
- OPM %
- —
- Other Income
- 51
- Interest
- 2
- Depreciation
- 40
- 278
- Tax %
- 31.72%
- Net Profit
- 190
- 3
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 418
- 299
- Operating Profit
- —
- OPM %
- —
- Other Income
- 25
- Interest
- 1
- Depreciation
- 30
- 145
- Tax %
- 17.04%
- Net Profit
- 120
- 0
- Equity Capital
- 113
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 113
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 248 | 308 | 356 | 633 | 1,103 | 1,231 | 1,057 | 1,419 | 1,845 | 2,124 | 2,002 | |
| 178 | 215 | 248 | 451 | 696 | 664 | 634 | 914 | 1,174 | 1,290 | 1,240 | |
| Operating Profit | 73 | 98 | 115 | 203 | 445 | 616 | 508 | 569 | 757 | 990 | — |
| OPM % | 30 | 32 | 32 | 32 | 40 | 50 | 48 | 40 | 41 | 47 | — |
| Other Income | 3 | 5 | 7 | 21 | 37 | 49 | 85 | 64 | 86 | 156 | 158 |
| Interest | 6 | 5 | 5 | 20 | 17 | 12 | 9 | 10 | 11 | 7 | 6 |
| Depreciation | 10 | 21 | 22 | 62 | 62 | 58 | 64 | 82 | 89 | 134 | 138 |
| 58 | 73 | 88 | 121 | 366 | 546 | 497 | 477 | 657 | 824 | 783 | |
| Tax % | 32 | 31 | 25 | 23 | 26 | 26 | 23 | 23 | 31 | 28 | 26 |
| Net Profit | 39 | 50 | 66 | 93 | 271 | 406 | 385 | 367 | 451 | 592 | 576 |
| EPS | 46 | 37 | 79 | 108 | 323 | 7 | 7 | 7 | 8 | 11 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19 | — |
| Minority Interest | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 1 | 1 | 2 | 5 | 7 | 7 | 7 | 8 | 11 | — |
| Minority Interest | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 1 | 1 | 2 | 5 | 7 | 7 | 7 | 8 | 11 | — |
Mar 2015
- 248
- 178
- Operating Profit
- 73
- OPM %
- 30
- Other Income
- 3
- Interest
- 6
- Depreciation
- 10
- 58
- Tax %
- 32
- Net Profit
- 39
- EPS
- 46
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2016
- 308
- 215
- Operating Profit
- 98
- OPM %
- 32
- Other Income
- 5
- Interest
- 5
- Depreciation
- 21
- 73
- Tax %
- 31
- Net Profit
- 50
- EPS
- 37
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2017
- 356
- 248
- Operating Profit
- 115
- OPM %
- 32
- Other Income
- 7
- Interest
- 5
- Depreciation
- 22
- 88
- Tax %
- 25
- Net Profit
- 66
- EPS
- 79
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2020
- 633
- 451
- Operating Profit
- 203
- OPM %
- 32
- Other Income
- 21
- Interest
- 20
- Depreciation
- 62
- 121
- Tax %
- 23
- Net Profit
- 93
- EPS
- 108
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2021
- 1,103
- 696
- Operating Profit
- 445
- OPM %
- 40
- Other Income
- 37
- Interest
- 17
- Depreciation
- 62
- 366
- Tax %
- 26
- Net Profit
- 271
- EPS
- 323
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2022
- 1,231
- 664
- Operating Profit
- 616
- OPM %
- 50
- Other Income
- 49
- Interest
- 12
- Depreciation
- 58
- 546
- Tax %
- 26
- Net Profit
- 406
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2023
- 1,057
- 634
- Operating Profit
- 508
- OPM %
- 48
- Other Income
- 85
- Interest
- 9
- Depreciation
- 64
- 497
- Tax %
- 23
- Net Profit
- 385
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2024
- 1,419
- 914
- Operating Profit
- 569
- OPM %
- 40
- Other Income
- 64
- Interest
- 10
- Depreciation
- 82
- 477
- Tax %
- 23
- Net Profit
- 367
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2025
- 1,845
- 1,174
- Operating Profit
- 757
- OPM %
- 41
- Other Income
- 86
- Interest
- 11
- Depreciation
- 89
- 657
- Tax %
- 31
- Net Profit
- 451
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
Mar 2026
- 2,124
- 1,290
- Operating Profit
- 990
- OPM %
- 47
- Other Income
- 156
- Interest
- 7
- Depreciation
- 134
- 824
- Tax %
- 28
- Net Profit
- 592
- EPS
- 11
- Dividend Payout %
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
TTM
- 2,002
- 1,240
- Operating Profit
- —
- OPM %
- —
- Other Income
- 158
- Interest
- 6
- Depreciation
- 138
- 783
- Tax %
- 26
- Net Profit
- 576
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 32%
- 5 Years:
- 14%
- 3 Years:
- 26%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 43%
- 5 Years:
- 17%
- 3 Years:
- 15%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 4%
RETURN ON EQUITY
- 10 Years:
- 33%
- 5 Years:
- 25%
- 3 Years:
- 21%
- Last Year:
- 22%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| 8 | 8 | 8 | 8 | 8 | 9 | 114 | 112 | 112 | 112 | |
| 89 | 138 | 213 | 413 | 693 | 1,346 | 1,627 | 1,813 | 2,264 | 2,897 | |
| 27 | 37 | 35 | 26 | 80 | 30 | 29 | 121 | 43 | 4 | |
| Trade Payables | 24 | 26 | 33 | 58 | 77 | 65 | 72 | 101 | 110 | 75 |
| 87 | 147 | 221 | 270 | 232 | 276 | 263 | 330 | 420 | 517 | |
| Total Liabilities | 235 | 355 | 510 | 776 | 1,091 | 1,726 | 2,105 | 2,477 | 2,949 | 3,606 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 91 | 86 | 258 | 306 | 361 | 329 | 449 | 483 | 705 | 783 | |
| Capital Work in Progress | 22 | 74 | 43 | 50 | 19 | 154 | 164 | 345 | 297 | 264 |
| 2 | 8 | 27 | 99 | 209 | 273 | 499 | 472 | 433 | 1,007 | |
| 37 | 47 | 58 | 125 | 35 | 58 | 129 | 211 | 340 | 125 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 490 | 450 | 591 | |
| Cash & Bank | 2 | 4 | 11 | 22 | 41 | 349 | 343 | 184 | 172 | 275 |
| 81 | 136 | 113 | 174 | 426 | 563 | 520 | 292 | 550 | 561 | |
| Total Assets | 235 | 355 | 510 | 776 | 1,091 | 1,726 | 2,105 | 2,477 | 2,949 | 3,606 |
| Total Debt | 77 | 119 | 191 | 159 | 100 | 35 | 125 | 233 | 109 | 51 |
| Net Working Capital | 31 | 61 | 68 | 156 | 331 | 867 | 1,159 | 1,143 | 1,162 | 1,477 |
| Contingent Liabilities | 0 | 0 | 0 | 8 | 11 | 6 | 226 | 250 | 54 | 90 |
| Book Value per Share | 116.13 | 174.14 | 263.68 | 503.43 | 826.75 | 1543.98 | 30.51 | 34.43 | 42.49 | 53.57 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 77 | 119 | 191 | 159 | 100 | 35 | 125 | 233 | 109 | 51 |
| Net Working Capital | 31 | 61 | 68 | 156 | 331 | 867 | 1,159 | 1,143 | 1,162 | 1,477 |
| Contingent Liabilities | 0 | 0 | 0 | 8 | 11 | 6 | 226 | 250 | 54 | 90 |
| Book Value per Share | 116.13 | 174.14 | 263.68 | 503.43 | 826.75 | 1543.98 | 30.51 | 34.43 | 42.49 | 53.57 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2015
- 8
- 89
- 27
- Trade Payables
- 24
- 87
- Total Liabilities
- 235
- 91
- Capital Work in Progress
- 22
- 2
- 37
- 0
- Cash & Bank
- 2
- 81
- Total Assets
- 235
- Total Debt
- 77
- Net Working Capital
- 31
- Contingent Liabilities
- 0
- Book Value per Share
- 116.13
- Face Value
- 10.00
- Total Debt
- 77
- Net Working Capital
- 31
- Contingent Liabilities
- 0
- Book Value per Share
- 116.13
- Face Value
- 10.00
Mar 2016
- 8
- 138
- 37
- Trade Payables
- 26
- 147
- Total Liabilities
- 355
- 86
- Capital Work in Progress
- 74
- 8
- 47
- 0
- Cash & Bank
- 4
- 136
- Total Assets
- 355
- Total Debt
- 119
- Net Working Capital
- 61
- Contingent Liabilities
- 0
- Book Value per Share
- 174.14
- Face Value
- 10.00
- Total Debt
- 119
- Net Working Capital
- 61
- Contingent Liabilities
- 0
- Book Value per Share
- 174.14
- Face Value
- 10.00
Mar 2017
- 8
- 213
- 35
- Trade Payables
- 33
- 221
- Total Liabilities
- 510
- 258
- Capital Work in Progress
- 43
- 27
- 58
- 0
- Cash & Bank
- 11
- 113
- Total Assets
- 510
- Total Debt
- 191
- Net Working Capital
- 68
- Contingent Liabilities
- 0
- Book Value per Share
- 263.68
- Face Value
- 10.00
- Total Debt
- 191
- Net Working Capital
- 68
- Contingent Liabilities
- 0
- Book Value per Share
- 263.68
- Face Value
- 10.00
Mar 2020
- 8
- 413
- 26
- Trade Payables
- 58
- 270
- Total Liabilities
- 776
- 306
- Capital Work in Progress
- 50
- 99
- 125
- 0
- Cash & Bank
- 22
- 174
- Total Assets
- 776
- Total Debt
- 159
- Net Working Capital
- 156
- Contingent Liabilities
- 8
- Book Value per Share
- 503.43
- Face Value
- 10.00
- Total Debt
- 159
- Net Working Capital
- 156
- Contingent Liabilities
- 8
- Book Value per Share
- 503.43
- Face Value
- 10.00
Mar 2021
- 8
- 693
- 80
- Trade Payables
- 77
- 232
- Total Liabilities
- 1,091
- 361
- Capital Work in Progress
- 19
- 209
- 35
- 0
- Cash & Bank
- 41
- 426
- Total Assets
- 1,091
- Total Debt
- 100
- Net Working Capital
- 331
- Contingent Liabilities
- 11
- Book Value per Share
- 826.75
- Face Value
- 10.00
- Total Debt
- 100
- Net Working Capital
- 331
- Contingent Liabilities
- 11
- Book Value per Share
- 826.75
- Face Value
- 10.00
Mar 2022
- 9
- 1,346
- 30
- Trade Payables
- 65
- 276
- Total Liabilities
- 1,726
- 329
- Capital Work in Progress
- 154
- 273
- 58
- 0
- Cash & Bank
- 349
- 563
- Total Assets
- 1,726
- Total Debt
- 35
- Net Working Capital
- 867
- Contingent Liabilities
- 6
- Book Value per Share
- 1543.98
- Face Value
- 10.00
- Total Debt
- 35
- Net Working Capital
- 867
- Contingent Liabilities
- 6
- Book Value per Share
- 1543.98
- Face Value
- 10.00
Mar 2023
- 114
- 1,627
- 29
- Trade Payables
- 72
- 263
- Total Liabilities
- 2,105
- 449
- Capital Work in Progress
- 164
- 499
- 129
- 0
- Cash & Bank
- 343
- 520
- Total Assets
- 2,105
- Total Debt
- 125
- Net Working Capital
- 1,159
- Contingent Liabilities
- 226
- Book Value per Share
- 30.51
- Face Value
- 2.00
- Total Debt
- 125
- Net Working Capital
- 1,159
- Contingent Liabilities
- 226
- Book Value per Share
- 30.51
- Face Value
- 2.00
Mar 2024
- 112
- 1,813
- 121
- Trade Payables
- 101
- 330
- Total Liabilities
- 2,477
- 483
- Capital Work in Progress
- 345
- 472
- 211
- 490
- Cash & Bank
- 184
- 292
- Total Assets
- 2,477
- Total Debt
- 233
- Net Working Capital
- 1,143
- Contingent Liabilities
- 250
- Book Value per Share
- 34.43
- Face Value
- 2.00
- Total Debt
- 233
- Net Working Capital
- 1,143
- Contingent Liabilities
- 250
- Book Value per Share
- 34.43
- Face Value
- 2.00
Mar 2025
- 112
- 2,264
- 43
- Trade Payables
- 110
- 420
- Total Liabilities
- 2,949
- 705
- Capital Work in Progress
- 297
- 433
- 340
- 450
- Cash & Bank
- 172
- 550
- Total Assets
- 2,949
- Total Debt
- 109
- Net Working Capital
- 1,162
- Contingent Liabilities
- 54
- Book Value per Share
- 42.49
- Face Value
- 2.00
- Total Debt
- 109
- Net Working Capital
- 1,162
- Contingent Liabilities
- 54
- Book Value per Share
- 42.49
- Face Value
- 2.00
Mar 2026
- 112
- 2,897
- 4
- Trade Payables
- 75
- 517
- Total Liabilities
- 3,606
- 783
- Capital Work in Progress
- 264
- 1,007
- 125
- 591
- Cash & Bank
- 275
- 561
- Total Assets
- 3,606
- Total Debt
- 51
- Net Working Capital
- 1,477
- Contingent Liabilities
- 90
- Book Value per Share
- 53.57
- Face Value
- 2.00
- Total Debt
- 51
- Net Working Capital
- 1,477
- Contingent Liabilities
- 90
- Book Value per Share
- 53.57
- Face Value
- 2.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 166 | 278 | 333 | 306 | 140 | 271 | 844 | |
| Cash from Investing | 0 | 0 | 0 | -109 | -196 | -205 | -376 | -221 | -147 | -702 |
| Cash from Financing | 0 | 0 | 0 | -48 | -63 | 181 | 64 | -77 | -136 | -40 |
| 0 | 0 | 0 | 9 | 18 | 308 | -6 | -158 | -12 | 103 | |
| Free Cash Flow | -30 | -68 | -163 | -62 | 193 | 177 | 115 | -153 | 15 | 670 |
| OCF / Net Profit | 0.00 | 0.00 | 0.00 | 1.79 | 1.02 | 0.82 | 0.79 | 0.38 | 0.60 | 1.43 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -129 | 78 | 261 | 271 | 347 | 824 |
| OCF / Net Profit | 0.00 | 0.00 | 0.00 | 1.79 | 1.02 | 0.82 | 0.79 | 0.38 | 0.60 | 1.43 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -129 | 78 | 261 | 271 | 347 | 824 |
Mar 2015
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -30
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
Mar 2016
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -68
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
Mar 2017
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -163
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
Mar 2020
- 166
- Cash from Investing
- -109
- Cash from Financing
- -48
- 9
- Free Cash Flow
- -62
- OCF / Net Profit
- 1.79
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.79
- Cumulative 5-Year FCF
- 0
Mar 2021
- 278
- Cash from Investing
- -196
- Cash from Financing
- -63
- 18
- Free Cash Flow
- 193
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- -129
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- -129
Mar 2022
- 333
- Cash from Investing
- -205
- Cash from Financing
- 181
- 308
- Free Cash Flow
- 177
- OCF / Net Profit
- 0.82
- Cumulative 5-Year FCF
- 78
- OCF / Net Profit
- 0.82
- Cumulative 5-Year FCF
- 78
Mar 2023
- 306
- Cash from Investing
- -376
- Cash from Financing
- 64
- -6
- Free Cash Flow
- 115
- OCF / Net Profit
- 0.79
- Cumulative 5-Year FCF
- 261
- OCF / Net Profit
- 0.79
- Cumulative 5-Year FCF
- 261
Mar 2024
- 140
- Cash from Investing
- -221
- Cash from Financing
- -77
- -158
- Free Cash Flow
- -153
- OCF / Net Profit
- 0.38
- Cumulative 5-Year FCF
- 271
- OCF / Net Profit
- 0.38
- Cumulative 5-Year FCF
- 271
Mar 2025
- 271
- Cash from Investing
- -147
- Cash from Financing
- -136
- -12
- Free Cash Flow
- 15
- OCF / Net Profit
- 0.60
- Cumulative 5-Year FCF
- 347
- OCF / Net Profit
- 0.60
- Cumulative 5-Year FCF
- 347
Mar 2026
- 844
- Cash from Investing
- -702
- Cash from Financing
- -40
- 103
- Free Cash Flow
- 670
- OCF / Net Profit
- 1.43
- Cumulative 5-Year FCF
- 824
- OCF / Net Profit
- 1.43
- Cumulative 5-Year FCF
- 824
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 46.14 | 59.44 | 78.50 | 110.62 | 319.75 | 462.10 | 6.75 | 6.57 | 8.07 | 10.54 |
| Book Value (₹) | 116.13 | 174.14 | 263.68 | 503.43 | 826.75 | 1543.98 | 30.51 | 34.43 | 42.49 | 53.57 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 |
| Cash EPS (₹) | 0.90 | 1.30 | 1.61 | 2.83 | 6.05 | 8.12 | 7.87 | 8.03 | 9.67 | 12.92 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 29.61% | 31.93% | 32.33% | 32.03% | 40.33% | 50.04% | 48.06% | 35.59% | 36.26% | 38.20% |
| Net Margin % | 15.72% | 16.27% | 18.56% | 14.65% | 24.59% | 32.94% | 36.44% | 25.88% | 24.38% | 27.11% |
| ROE % | 49.99% | 41.23% | 36.02% | 28.84% | 48.30% | 39.44% | 24.89% | 20.04% | 20.99% | 21.98% |
| ROCE % | 39.87% | 34.59% | 27.35% | 28.38% | 55.36% | 50.94% | 31.08% | 24.21% | 28.55% | 29.62% |
| 18.74% | 16.98% | 15.28% | 14.42% | 29.07% | 28.79% | 20.11% | 16.04% | 16.64% | 18.06% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 64 | 83 | 81 | 52 | 60 | 86 | 104 | 98 | 93 | 87 |
| Inventory Days | 50 | 50 | 54 | 53 | 27 | 14 | 32 | 44 | 54 | 39 |
| Payable Days | 85 | 70 | 80 | 67 | 54 | 63 | 74 | 53 | 52 | 42 |
| 29 | 63 | 55 | 38 | 32 | 37 | 62 | 90 | 95 | 84 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.76x | 0.79x | 0.85x | 0.38x | 0.14x | 0.03x | 0.07x | 0.12x | 0.05x | 0.02x |
| Interest Coverage (x) | 11.47x | 15.53x | 17.24x | 6.91x | 22.55x | 45.81x | 58.01x | 50.43x | 63.40x | 117.83x |
| 1.41x | 1.51x | 1.54x | 1.63x | 1.93x | 3.48x | 5.16x | 3.49x | 3.39x | 3.79x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 92.77% | 24.27% | 15.49% | 77.75% | 74.36% | 11.60% | -14.16% | 34.29% | 29.96% | 15.17% |
| Operating Profit Growth % | 101.64% | 34.04% | 16.94% | 76.09% | 119.52% | 38.47% | -17.56% | 11.99% | 33.05% | 30.79% |
| Net Profit Growth % | 136.80% | 28.57% | 31.79% | 40.29% | 192.65% | 49.48% | -5.02% | -4.64% | 22.86% | 31.14% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2.69% | 22.86% | 30.53% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 62.29x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 12.25x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.30% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.28x | 0.06x | 37.02x |
Mar 2015
- EPS (₹)
- 46.14
- Book Value (₹)
- 116.13
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.90
- Operating Margin %
- 29.61%
- Net Margin %
- 15.72%
- ROE %
- 49.99%
- ROCE %
- 39.87%
- 18.74%
- Debtor Days
- 64
- Inventory Days
- 50
- Payable Days
- 85
- 29
- Debt to Equity (x)
- 0.76x
- Interest Coverage (x)
- 11.47x
- 1.41x
- Revenue Growth %
- 92.77%
- Operating Profit Growth %
- 101.64%
- Net Profit Growth %
- 136.80%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2016
- EPS (₹)
- 59.44
- Book Value (₹)
- 174.14
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.30
- Operating Margin %
- 31.93%
- Net Margin %
- 16.27%
- ROE %
- 41.23%
- ROCE %
- 34.59%
- 16.98%
- Debtor Days
- 83
- Inventory Days
- 50
- Payable Days
- 70
- 63
- Debt to Equity (x)
- 0.79x
- Interest Coverage (x)
- 15.53x
- 1.51x
- Revenue Growth %
- 24.27%
- Operating Profit Growth %
- 34.04%
- Net Profit Growth %
- 28.57%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 78.50
- Book Value (₹)
- 263.68
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.61
- Operating Margin %
- 32.33%
- Net Margin %
- 18.56%
- ROE %
- 36.02%
- ROCE %
- 27.35%
- 15.28%
- Debtor Days
- 81
- Inventory Days
- 54
- Payable Days
- 80
- 55
- Debt to Equity (x)
- 0.85x
- Interest Coverage (x)
- 17.24x
- 1.54x
- Revenue Growth %
- 15.49%
- Operating Profit Growth %
- 16.94%
- Net Profit Growth %
- 31.79%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 110.62
- Book Value (₹)
- 503.43
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.83
- Operating Margin %
- 32.03%
- Net Margin %
- 14.65%
- ROE %
- 28.84%
- ROCE %
- 28.38%
- 14.42%
- Debtor Days
- 52
- Inventory Days
- 53
- Payable Days
- 67
- 38
- Debt to Equity (x)
- 0.38x
- Interest Coverage (x)
- 6.91x
- 1.63x
- Revenue Growth %
- 77.75%
- Operating Profit Growth %
- 76.09%
- Net Profit Growth %
- 40.29%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 319.75
- Book Value (₹)
- 826.75
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.05
- Operating Margin %
- 40.33%
- Net Margin %
- 24.59%
- ROE %
- 48.30%
- ROCE %
- 55.36%
- 29.07%
- Debtor Days
- 60
- Inventory Days
- 27
- Payable Days
- 54
- 32
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 22.55x
- 1.93x
- Revenue Growth %
- 74.36%
- Operating Profit Growth %
- 119.52%
- Net Profit Growth %
- 192.65%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 462.10
- Book Value (₹)
- 1543.98
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.12
- Operating Margin %
- 50.04%
- Net Margin %
- 32.94%
- ROE %
- 39.44%
- ROCE %
- 50.94%
- 28.79%
- Debtor Days
- 86
- Inventory Days
- 14
- Payable Days
- 63
- 37
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 45.81x
- 3.48x
- Revenue Growth %
- 11.60%
- Operating Profit Growth %
- 38.47%
- Net Profit Growth %
- 49.48%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 6.75
- Book Value (₹)
- 30.51
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.87
- Operating Margin %
- 48.06%
- Net Margin %
- 36.44%
- ROE %
- 24.89%
- ROCE %
- 31.08%
- 20.11%
- Debtor Days
- 104
- Inventory Days
- 32
- Payable Days
- 74
- 62
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 58.01x
- 5.16x
- Revenue Growth %
- -14.16%
- Operating Profit Growth %
- -17.56%
- Net Profit Growth %
- -5.02%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 6.57
- Book Value (₹)
- 34.43
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.03
- Operating Margin %
- 35.59%
- Net Margin %
- 25.88%
- ROE %
- 20.04%
- ROCE %
- 24.21%
- 16.04%
- Debtor Days
- 98
- Inventory Days
- 44
- Payable Days
- 53
- 90
- Debt to Equity (x)
- 0.12x
- Interest Coverage (x)
- 50.43x
- 3.49x
- Revenue Growth %
- 34.29%
- Operating Profit Growth %
- 11.99%
- Net Profit Growth %
- -4.64%
- -2.69%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.28x
Mar 2025
- EPS (₹)
- 8.07
- Book Value (₹)
- 42.49
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 9.67
- Operating Margin %
- 36.26%
- Net Margin %
- 24.38%
- ROE %
- 20.99%
- ROCE %
- 28.55%
- 16.64%
- Debtor Days
- 93
- Inventory Days
- 54
- Payable Days
- 52
- 95
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 63.40x
- 3.39x
- Revenue Growth %
- 29.96%
- Operating Profit Growth %
- 33.05%
- Net Profit Growth %
- 22.86%
- 22.86%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.06x
Mar 2026
- EPS (₹)
- 10.54
- Book Value (₹)
- 53.57
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 12.92
- Operating Margin %
- 38.20%
- Net Margin %
- 27.11%
- ROE %
- 21.98%
- ROCE %
- 29.62%
- 18.06%
- Debtor Days
- 87
- Inventory Days
- 39
- Payable Days
- 42
- 84
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 117.83x
- 3.79x
- Revenue Growth %
- 15.17%
- Operating Profit Growth %
- 30.79%
- Net Profit Growth %
- 31.14%
- 30.53%
- P/E (x)
- 62.29x
- P/B (x)
- 12.25x
- Dividend Yield %
- 0.30%
- 37.02x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-07-27 - Anthem Biosciences Limited has informed the Exchange about Transcript
- Shareholders meeting
2026-07-24 - Anthem Biosciences Limited has submitted the Exchange the voting results and a copy Srutinizers report of the 20th Annual General Meeting held on July 22, 2026.
Annual Reports
Nothing filed yet.
Credit Ratings
- Credit Rating
2026-07-03 - Anthem Biosciences Limited has informed the Exchange about Credit Rating
Concalls
Jul 2026
May 2026
Feb 2026